InVision Medical Technology
AI Diagnosis of Heart Disease
About
At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.
Founders
- Bryan He
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in InVision Medical Technology.
See family office activity